NAP1L1 and cardiac hypertrophy: Through phalloidin staining, we found that Nap1l1 p.D349E caused a significant increase in the cell surface area (CSA) of cardiomyocytes, which was consistent with the cardiac hypertrophy phenotype of HCM patients (Fig. 4J).